Eiger BioPharmaceuticals
Patents, Design & Utilities
Last updated:
List of all Eiger BioPharmaceuticals patents 23 in total
| Status | Patent |
|---|---|
Grant | Utility: Treatment of hepatitis delta virus infection Filling date: 6 Sep 2025 Issue date: 26 Apr 2022 |
Application | Utility: TREATMENT OF HEPATITIS DELTA VIRUS INFECTION Filling date: 6 Sep 2025 Issue date: 27 Jan 2022 |
Application | Utility: COMPOSITIONS OF EXENDIN-4 DERIVATIVES Filling date: 6 Sep 2025 Issue date: 2 Dec 2021 |
Application | Utility: METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS Filling date: 6 Sep 2025 Issue date: 2 Dec 2021 |
Application | Utility: AVEXITIDE FOR THE TREATMENT OF HYPERINSULINEMIC HYPOGLYCEMIA Filling date: 6 Sep 2025 Issue date: 4 Nov 2021 |
Application | Utility: Buffered Formulations Of Exendin (9-39) Filling date: 6 Sep 2025 Issue date: 14 Oct 2021 |
Grant | Utility: Treatment of hyperinsulinemic hypoglycemia with exendin-4 derivatives Filling date: 6 Sep 2025 Issue date: 14 Sep 2021 |
Application | Utility: METHOD OF TREATING LAMINOPATHIES Filling date: 6 Sep 2025 Issue date: 2 Sep 2021 |
Application | Utility: TREATMENT OF HEPATITIS DELTA VIRUS INFECTION WITH INTERFERON LAMBDA Filling date: 6 Sep 2025 Issue date: 29 Jul 2021 |
Application | Utility: TREATMENT OF HEPATITIS DELTA VIRUS INFECTION WITH INTERFERON LAMBDA Filling date: 6 Sep 2025 Issue date: 24 Jun 2021 |
Grant | Utility: Buffered formulations of exendin (9-39) Filling date: 6 Sep 2025 Issue date: 1 Jun 2021 |
Application | Utility: METHOD OF TREATING LAMINOPATHIES Filling date: 6 Sep 2025 Issue date: 29 Apr 2021 |
Application | Utility: PHARMACEUTICAL COMPOSITIONS COMPRISING LONAFARNIB AND RITONAVIR Filling date: 6 Sep 2025 Issue date: 1 Apr 2021 |
Grant | Utility: Treatment of hepatitis delta virus infection with interferon lambda Filling date: 6 Sep 2025 Issue date: 23 Mar 2021 |
Application | Utility: TREATMENT OF HEPATITIS DELTA VIRUS INFECTION Filling date: 6 Sep 2025 Issue date: 3 Dec 2020 |
Grant | Utility: Pharmaceutical compositions comprising lonafarnib and ritonavir Filling date: 6 Sep 2025 Issue date: 17 Nov 2020 |
Grant | Utility: Treatment of hepatitis delta virus infection Filling date: 6 Sep 2025 Issue date: 10 Nov 2020 |
Application | Utility: TREATMENT OF HYPERINSULINEMIC HYPOGLYCEMIA WITH EXENDIN-4 DERIVATIVES Filling date: 6 Sep 2025 Issue date: 24 Sep 2020 |
Application | Utility: METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS Filling date: 6 Sep 2025 Issue date: 30 Jul 2020 |
Grant | Utility: Treatment of hyperinsulinemic hypoglycemia with exendin-4 derivatives Filling date: 6 Sep 2025 Issue date: 19 May 2020 |
Grant | Utility: Methods and pharmaceutical compositions for the treatment of non-alcoholic steatohepatitis Filling date: 6 Sep 2025 Issue date: 17 Mar 2020 |
Application | Utility: Buffered Formulations Of Exendin (9-39) Filling date: 6 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS Filling date: 6 Sep 2025 Issue date: 10 Oct 2019 |
Showing 1 to 23 of 23 patents.